Literatur
Italiano A, Di Mauro I, Rapp J et al (2016) Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study. Lancet Oncol 17(4):532–538
Brüderlein S, Sommer JB, Meltzer PS, Li S, Osada T, Ng D, Möller P, Alcorta DA, Kelley MJ (2010) Molecular characterization of putative chordoma cell lines. Sarcoma 2010:630129. https://doi.org/10.1155/2010/630129
Jäger D, Barth TFE, Brüderlein S et al (2017) HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas. Sci Rep 7(1):2032
Scheipl S, Barnard M, Cottone L, Jorgensen M, Drewry DH, Zuercher WJ, Turlais F, Ye H, Leite AP, Smith JA, Leithner A, Möller P, Brüderlein S, Guppy N, Amary F, Tirabosco R, Strauss SJ, Pillay N, Flanagan AM (2016) EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen. J Pathol 239:320–334. https://doi.org/10.1002/path.4729
de Alava E, Gerald WL (2000) Molecular biology of the Ewing’s sarcoma/primitive neuroectodermal tumor family. J Clin Oncol 18(1):204–213. https://doi.org/10.1200/JCO.2000.18.1.204
Renzi S, Anderson ND, Light N, Gupta A (2019) Ewing-like sarcoma: an emerging family of round cell sarcomas. J Cell Physiol 234(6):7999–8007. https://doi.org/10.1002/jcp.27558
Heyer EE, Blackburn J (2020) Sequencing strategies for fusion gene detection. Bioessays 42:2000016. https://doi.org/10.1002/bies.202000016
Wang L (2013) Identification of cancer gene fusions based on advanced analysis of the human genome or transcriptome. Front Med 7(3):280–289. https://doi.org/10.1007/s11684-013-0265-3
Chang KTE, Goytain A, Tucker T, Karsan A, Lee CH, Nielsen TO, Ng TL (2018) Development and evaluation of a pan-sarcoma fusion gene detection assay using the Nanostring nCounter platform. J Mol Diagn 20(1):63–77. https://doi.org/10.1016/j.jmoldx.2017.09.007
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
S. Scheil-Bertram und E. Wardelmann geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
The supplement containing this article ist not sponsored by industry.
Rights and permissions
About this article
Cite this article
Scheil-Bertram, S., Wardelmann, E. Sitzungsbericht der AG Knochen‑, Gelenk- und Weichgewebspathologie. Pathologe 41 (Suppl 2), 178–180 (2020). https://doi.org/10.1007/s00292-020-00856-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-020-00856-y